Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Dr. Gillis' Wellness Center

Two GLP-1 desks, one scoreboard. We put CoreAge Rx and Dr. Gillis' Wellness Center head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 103 · Grade C

Dr. Gillis' Wellness Center

Visit Dr. Gillis' Wellness Center Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 72 on our six-factor Brief Score — The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

That doesn't make Dr. Gillis' Wellness Center a bad call — it's best for patients wanting sublingual odt glp-1 tablets or a needle-free weight-loss option. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 on the board — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
36
Supply Reliability
95
76
Transparency
90
88
Access Breadth
93
86
Clinical Oversight
92
84
Track Record
88
78
CoreAge RxBrief Score 94 · 72Dr. Gillis' Wellness Center

Price, coverage & the tracker

CoreAge RxDr. Gillis' Wellness Center
Brief Score94/100 (A)72/100 (C)
Semaglutide$149/moFrom $149/mo (starting dose, compounded)
Tirzepatide$349/moNot disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: Flat rate held for a third straight cycle — no first-month teaser to reset.

Dr. Gillis' Wellness Center: New to the tracker on 1 August 2026. The published line reads From $149/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.